Please use this identifier to cite or link to this item:
http://repository.kln.ac.lk/handle/123456789/22862
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Mettananda, K.C.D. | - |
dc.date.accessioned | 2021-06-25T14:42:31Z | - |
dc.date.available | 2021-06-25T14:42:31Z | - |
dc.date.issued | 2021 | - |
dc.identifier.citation | Journal of the Ceylon College of Physicians.2021; 52(1):26–29. | en_US |
dc.identifier.issn | 2448-9514 | - |
dc.identifier.uri | http://repository.kln.ac.lk/handle/123456789/22862 | - |
dc.description | Not indexed in MEDLINE | en_US |
dc.description.abstract | ABSTRACT: In patients presenting with transient ischaemic attacks and acute minor noncardioembolic ischemic strokes (NIHSS score ≤3) who did not receive intravenous alteplase, treatment with dual antiplatelet therapy with aspirin and clopidogrel, started within 24 hours of symptom onset and continued for 21 days is effective in reducing a recurrent ischemic stroke up to 90 days from the symptom onset. However, as the long-term risk of major disabling bleeding with aspirin-based antiplatelet treatment is higher in patients aged 75 years or older, routine co-prescription of proton pump inhibitor should be encouraged. KEYWORDS: Antiplatelet, Stroke, Transient-ischaemicattack, Prevention, Dual-antiplatelet | en_US |
dc.language.iso | en_US | en_US |
dc.publisher | Ceylon College of Physicians | en_US |
dc.subject | Antiplatelet therapy | en_US |
dc.title | Antiplatelet therapy for transient ischaemic attacks and acute minor strokes: current best practice and future | en_US |
dc.type | Article | en_US |
Appears in Collections: | Journal/Magazine Articles |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Antiplatelet therapy for transient ischaemic attacks.pdf | 111.16 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.